Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally Recurrent Inoperable or Metastatic TNBC By Ogkologos - April 28, 2026 115 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPION-Breast02 study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Predicting future breast cancer with precision March 22, 2021 Opinion: ‘Beating cancer means beating it for everyone’ January 29, 2021 Trial Results Support SBRT as a Standard Option for Some Prostate... November 21, 2024 Study Adds to Debate about Mammography in Older Women September 12, 2023 Load more HOT NEWS Abiraterone Acetate Plus Prednisone and LHRH Analogue is Active and Safe... PET Positivity After Two Cycles of ABVD Is Associated with a... Studies Test CAR T-Cell Therapies Designed to Overcome Key Limitations RNF43 Mutations Warrant Further Validation for Potential to Prioritise Anti-EGFR/BRAF Combinations...
